TrialJournal for immunotherapy of cancer2024

Comparison of efficacy discrepancy between early-phase clinical trials and phase III trials of PD-1/PD-L1 inhibitors.

Xiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.